IFNA1 and acute lymphoblastic leukemia: In fact, IFN-α had been used as adjuvant29–31 or maintenance treatments in ALL patients32,33, which was reported to help to achieve CR again in ALL patients who experienced relapse after allo-HSCT34,35.